Clinical Trial Update: Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin lispro biphasic 25 to Humalog Mix 25 in adults with type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Humalog Mix 25 (insulin lispro mix 25)
• Insulin lispro biphasic 25 (insulin lispro biphasic 25)

Snippet

Sponsor: Geropharm | Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus | Phase 3 | Status: COMPLETED